Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
| superior_oblique_myokymia [2017/05/17 03:50] – [Treatment] Scott Larson | superior_oblique_myokymia [2025/04/18 20:40] (current) – external edit 127.0.0.1 | ||
|---|---|---|---|
| Line 25: | Line 25: | ||
| === Medical Treatment === | === Medical Treatment === | ||
| * topical betaxolol (Betoptic 0.5%, Betoptic S 0.25%) BID- one report of success | * topical betaxolol (Betoptic 0.5%, Betoptic S 0.25%) BID- one report of success | ||
| - | * [[carbamazepine|carbamazepine]] (tegretol) 100 mg BID or TID to start and moving | + | * [[carbamazepine|carbamazepine]] (tegretol) 100 mg BID or TID to start and move to up to 200 mg TID as needed |
| * potential side effects including leucopenia, acute renal failure, thromboembolism, | * potential side effects including leucopenia, acute renal failure, thromboembolism, | ||
| * blood counts (CBC, including platelets and reticulocytes), | * blood counts (CBC, including platelets and reticulocytes), | ||